First Time Loading...

BioCardia Inc
NASDAQ:BCDA

Watchlist Manager
BioCardia Inc Logo
BioCardia Inc
NASDAQ:BCDA
Watchlist
Price: 0.3865 USD 1.74% Market Closed
Updated: May 7, 2024
Section:
 

Wall Street
Price Targets

BCDA Price Targets Summary
BioCardia Inc

There are no price targets for BCDA.
BCDA Lowest Forecast
Wall Street Target
Not Available
BCDA Average Forecast
Wall Street Target
Not Available
BCDA Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BioCardia Inc Competitors:
Price Targets
MRUS
Merus NV
31% Upside
BNTX
BioNTech SE
30% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
27% Upside
N
NYKD
Nykode Therapeutics ASA
186% Upside
MRUS
Merus NV
31% Upside
BNTX
BioNTech SE
30% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
27% Upside
N
NYKD
Nykode Therapeutics ASA
186% Upside
TGTX
TG Therapeutics Inc
88% Upside
A
ALVO
Alvotech SA
17% Upside
CTMX
CytomX Therapeutics Inc
32% Downside
4978
ReproCell Inc
94% Upside

Revenue
Forecast

Revenue Estimate
BioCardia Inc

For the last 8 years the compound annual growth rate for BioCardia Inc's revenue is -8%. The projected CAGR for the next 3 years is 173%.

-8%
Past Growth
173%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
BioCardia Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
BioCardia Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
What are analyst estimates?

See Also

Summary
BCDA intrinsic value, competitors valuation, and company profile.
DCF Valuation
BCDA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BCDA stock valuation using valuation multiples.
Wall Street Estimates
BCDA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BCDA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCDA's stock price target?
Not Available

BCDA doesn't have any price targets made by Wall Street professionals.

What is BioCardia Inc's Revenue forecast?
Projected CAGR
173%

For the last 8 years the compound annual growth rate for BioCardia Inc's revenue is -8%. The projected CAGR for the next 3 years is 173%.

ALPHA SPREAD
Join more than 134,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.